CD274 and ovarian cancer: While several studies have indeed suggested that PD-L1 is a good prognostic (and therapeutic) target in ovarian cancer, the results are inconsistent and many other studies have found no correlation between PD-L1 expression by ICH and PFS or OS in ovarian cancer [26].